Abstract
The pathobiology-based approach to research and development has been the dominant paradigm for successful drug discovery over the last decades. We propose that the molecular and cellular events that govern a resolving, rather than an evolving, disease may reveal new druggable pathways.
| Original language | English |
|---|---|
| Pages (from-to) | 229le2 |
| Journal | Science Translational Medicine |
| Volume | 6 |
| Issue number | 229 |
| DOIs | |
| Publication status | Published - 2014 |